ArticleJTO clinical and research reports2022

Osimertinib-Induced Cutaneous Vasculitis Responsive to Low-Dose Dapsone Without Interruption of Anticancer Therapy: A Case Report and Review of the Literature.

Christopher Iriarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.